147
Views
39
CrossRef citations to date
0
Altmetric
Research Article

A novel nanovesicular carrier system to deliver drug topically

&
Pages 673-685 | Received 14 Aug 2011, Accepted 03 Apr 2012, Published online: 22 May 2012

References

  • Stern RS. The epidemiology of cutaneous disease. In: Freedberg, I.M.Fitzpatrick, T.B.. (Eds.) Fitzpatrick’s Dermatology in general medicine, 5th ed. McGraw-Hill, NewYork. 1999: 7–12.
  • Kaur IP, Kakkar S. Topical delivery of antifungal agents. Expert Opin Drug Deliv 2010;7:1303–1327.
  • Mezei M, Gulasekharam V. Liposomes–a selective drug delivery system for the topical route of administration. Lotion dosage form. Life Sci 1980;26:1473–1477.
  • Mezei M, Gulasekharam V. Liposomes–a selective drug delivery system for the topical route of administration: gel dosage form. J Pharm Pharmacol 1982;34:473–474.
  • El Maghraby GM, Williams AC, Barry BW. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm 2000;196:63–74.
  • Gupta PN, Mishra V, Singh P, Rawat A, Dubey P, Mahor S et al. Tetanus toxoid-loaded transfersomes for topical immunization. J Pharm Pharmacol 2005;57:295–301.
  • Elsayed MM, Abdallah OY, Naggar VF, Khalafallah NM. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 2007;332:1–16.
  • Cevc G, Blume G, Schatzlein A. Transfersomes-mediated transepidermal delivery improves the regiospecificity and biological activity of corticosteroids in vivo. J Control Release. 1997;45:211–226.
  • Lasch J, Laub R, Wohlrab W. How deep do intact liposomes penetrate into human skin? J Control Release. 1991;18:55–58.
  • Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release 2000;65:403–418.
  • Cevc G, Gebauer D, Stieber J, Schätzlein A, Blume G. Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim Biophys Acta 1998;1368:201–215.
  • Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim Biophys Acta 1992;1104:226–232.
  • van den Bergh BA, Bouwstra JA, Junginger HE, Wertz PW. Elasticity of vesicles affects hairless mouse skin structure and permeability. J Control Release 1999;62:367–379.
  • Touitou E, Alkabes M, Dayan N. Ethosomes: novel lipid vesicular system for enhanced delivery. Pharm Res. 1997;S14:305–306.
  • Vaibhav D, Dinesh M, Tathagata D, et al. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release. 2007;123:148–154.
  • Cevc G, Blume G, Schatzlein A, et al. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv Drug Deliv Rev. 1996;18:349–378.
  • Manosroi A, Jantrawut P, Manosroi J. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm 2008;360:156–163.
  • El Maghraby GM, Williams AC, Barry BW. Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes. J Pharm Pharmacol 2001;53:1311–1322.
  • Gallarate M, Chirio D, Trotta M, et al. Deformable liposomes as topical formulations containing alpha-tocopherol. J Disper Sci Technol. 2006;27:703–713.
  • Peira E, Trotta M, Carlotti ME, et al. Elastic positively-charged liposomes for topical administration of acyclovir. J Drug Deliv Sci Technol. 2007;17:321–324.
  • Trotta M, Peira E, Carlotti ME, Gallarate M. Deformable liposomes for dermal administration of methotrexate. Int J Pharm 2004;270:119–125.
  • Honeywell-Nguyen PL, Frederik PM, Bomans PH, Junginger HE, Bouwstra JA. Transdermal delivery of pergolide from surfactant-based elastic and rigid vesicles: characterization and in vitro transport studies. Pharm Res 2002;19:991–997.
  • Honeywell-Nguyen PL, Van Den Bussche MH, Junginger HE, et al. The effect of surfactant -based elastic and rigid vesicles on the permeation of lidocain across human skin. STP Pharm Sci. 2002b;1:257–262.
  • Honeywell-Nguyen PL, Arenja S, Bouwstra JA. Skin penetration and mechanisms of action in the delivery of the D2-agonist rotigotine from surfactant-based elastic vesicle formulations. Pharm Res 2003;20:1619–1625.
  • Dubey V, Mishra D, Dutta T, Nahar M, Saraf DK, Jain NK. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Release 2007;123:148–154.
  • Xu QA, Lawrence AT. (Eds.) Stability-indicating HPLC Methods for Drug Analysis, published jointly by Pharmaceutical Press and American Pharmacists Association, University of Michigan, USA. 2003:449.
  • O’Brien TP. Therapy of ocular fungal infections. Ophthalmol Clin North Am. 1999;12:33–50.
  • Hawkins GS, Reifenrath WG. Influence of skin source, penetration cell fluid, and partition coefficient on in vitro skin penetration. J Pharm Sci 1986;75:378–381.
  • Alberti I, Kalia YN, Naik A, Bonny J, Guy RH. Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum, in vivo. Int J Pharm 2001;219:11–19.
  • Chatterjee CC. In: Human Physiology. vol. I, 11 edn: Medical Allied Agency, Calcutta. 1985:174.
  • Immordino ML, Brusa P, Arpicco S, Stella B, Dosio F, Cattel L. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. J Control Release 2003;91:417–429.
  • van den Bergh BA, Wertz PW, Junginger HE, Bouwstra JA. Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. Int J Pharm 2001;217:13–24.
  • Raza K, Negi P, Takyar S, Shukla A, Amarji B, Katare OP. Novel dithranol phospholipid microemulsion for topical application: development, characterization and percutaneous absorption studies. J Microencapsul 2011;28:190–199.
  • Raza K, Singh B, Mahajan A, Negi P, Bhatia A, Katare OP. Design and evaluation of flexible membrane vesicles (FMVs) for enhanced topical delivery of capsaicin. J Drug Target 2011;19:293–302.
  • Khan G. Controlled Release Oral Dosage Forms: Some recent, advances in matrix type drug delivery systems. The Sciences. 2001;1:350–354.
  • Morkhade DM, Fulzele SV, Satturwar PM, et al. Gum copal and gum dammar: novel matrix forming material for sustained drug delivery. Indian J Pharm Sci. 2006;68:53–58.
  • Higuchi T. Mechanism of sustained-action medication. theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145–1149.
  • Peppas NA, JJ S. A simple equation for the descripition of solute release: III. Coupling of diffusion and relaxation. Int J Pharm. 1989;57:169–172.
  • Joshi M, Patravale V. Formulation and evaluation of Nanostructured Lipid Carrier (NLC)-based gel of Valdecoxib. Drug Dev Ind Pharm 2006;32:911–918.
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55–63.
  • Bhushan S, Kumar A, Malik F, Andotra SS, Sethi VK, Kaur IP et al. A triterpenediol from Boswellia serrata induces apoptosis through both the intrinsic and extrinsic apoptotic pathways in human leukemia HL-60 cells. Apoptosis 2007;12:1911–1926.
  • Shishu, Rajan, S, Kamalpreet. Development of novel microemulsion-based topical formulations of acyclovir for the treatment of cutaneous herpetic infections. AAPS PharmSciTech. 2009;10:559–565.
  • Rao Y, Zheng F, Zhang X, Gao J, Liang W. In vitro percutaneous permeation and skin accumulation of finasteride using vesicular ethosomal carriers. AAPS PharmSciTech 2008;9:860–865.
  • Barry AL, Cullis PR. Direct NMR evidence for ethanol binding to the lipid-water interface of phospholipid bilayers. Biochem. 1995;33:8082–8088.
  • Lasic D, Weiner N, Riaz M, et al. Liposomes. In: Lieberman A., Rieger M., Banker G.. (Eds.) Pharmaceutical Dosage Forms: Disperse Systems, Marcel Dekker, NY. 1998;3:8–43.
  • Gompper G, Kroll DM. Driven transport of fluid vesicles through narrow pores. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 1995;52:4198–4208.
  • Planas ME, Gonzalez P, Rodriguez L, Sanchez S, Cevc G. Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Anesth Analg 1992;75:615–621.
  • Hillgren A, Evertsson H, Aldén M. Interaction between lactate dehydrogenase and Tween 80 in aqueous solution. Pharm Res 2002;19:504–510.
  • Trotta M, Peira E, Debernardi F, Gallarate M. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm 2002;241:319–327.
  • Plessis J, Ramachandran C, Weiner N, et al. The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage. Int J Pharm. 1996;127:273–278.
  • El Maghraby GM, Barry BW, Williams AC. Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci 2008;34:203–222.
  • Guo J, Ping Q, Sun G, Jiao C. Lecithin vesicular carriers for transdermal delivery of cyclosporin A. Int J Pharm 2000;194:201–207.
  • Jain S, Jain P, Umamaheshwari RB, Jain NK. Transfersomes–a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev Ind Pharm 2003;29:1013–1026.
  • Barar FSKE, Chemotherapy of Fungal Diseases (Antifungal Drugs) in Essentials of Pharmacotherapeutics, S. Chand and Company Ltd., New Delhi. 2000, 501.
  • Verma DD, Verma S, Blume G, Fahr A. Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur J Pharm Biopharm 2003;55:271–277.
  • Esposito E, Zanella C, Cortesi R, et al. Influence of liposomal formulation parameters on the in vitro absorption of methyl nicotinate. 1998;172:255–260.
  • Du Plessis J, Ramachandran C, Weiner N, et al. The influence of particle size of liposomes on the disposition of drug into the skin. Int J Pharm. 1994;103:277–282.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.